StockVS

Artius II Acquisition Inc. (AACBU) 股票分析

金融服务

Artius II Acquisition Inc.

$10.53

+$0.00 (+0.00%)

最后更新: 2026年5月26日

价格走势

分析

公司概述

Artius II Acquisition Inc. operates as a special purpose acquisition company with no significant current operations, intending to complete a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more target businesses. The company focuses specifically on technology-enabled businesses, positioning itself within the Financial Services sector under the industry classification of Shell Companies, which implies a transitional state pending a definitive corporate combination. As of the latest available data, the company holds a market capitalization of $269.37M, while its annual revenue is not applicable due to its status as a shell entity awaiting an acquisition target. The absence of an employee count reflects the company's current structure as a vehicle rather than an operating enterprise, indicating that its market capitalization of $269.37M represents investor capital allocated to a potential deal rather than revenue-generating assets or operational scale.

财务健康

The company reports a net income of $136,237 over the trailing twelve months, whereas revenue and EBITDA are listed as not applicable, revealing a cost structure where nominal operating expenses have generated a small profit despite a lack of traditional top-line revenue. Free cash flow is not applicable for the company, which suggests that the firm currently lacks the operational cash generation typical of mature businesses, relying instead on capital raised or existing reserves for liquidity. All three margin metrics—gross margin, operating margin, and profit margin—are recorded at 0.0%, indicating that the company has not yet engaged in significant commercial transactions that would establish a cost-of-sales or operating leverage baseline. The balance sheet shows a cash position of $32,193 against zero debt, while the debt-to-equity ratio is not applicable, presenting a technically conservative leverage profile albeit with minimal absolute liquidity reserves. However, the current ratio stands at 0.14, a figure that indicates significant short-term liquidity constraints, suggesting current assets are insufficient to cover current liabilities without relying on external financing or the completion of a business combination. Return on Equity and Return on Assets are not applicable for standard equity returns, though the return on assets is explicitly stated at -4.3%, which reveals that the company's asset base is currently generating a negative return, likely due to accounting treatments associated with shell company structures prior to an acquisition.

估值评估

The trailing P/E ratio and forward P/E ratio are both listed as not applicable, implying that traditional earnings-based valuation models cannot be applied to a company with negligible or negative earnings relative to its market capitalization. The price-to-book ratio is -21.49, a negative figure that indicates the market is pricing the company below its book value, a common characteristic for shell companies that may carry intangible liabilities or specific accounting adjustments. Neither the price-to-sales ratio nor the EV/EBITDA multiple is applicable, suggesting that alternative valuation metrics are also distorted by the lack of operating data and the speculative nature of the asset. The stock has traded within a 52-week range between a high of $12.15 and a low of $10.06, with the current market capitalization of $269.37M reflecting a price point that requires precise calculation relative to these bounds to determine exact positioning. The beta value is not applicable, meaning there is no historical volatility data available to compare the stock's price movements against the broader market index, which is typical for newly formed or pending acquisition vehicles.

Growth & Income

Revenue growth and earnings growth rates are both not applicable, as the company has not yet generated the recurring revenue streams necessary to calculate year-over-year expansion metrics. Since the company does not pay dividends, the dividend yield and payout ratio are not applicable, indicating that all available capital is theoretically available for reinvestment into a future business combination rather than distribution to shareholders. The absence of a dividend policy aligns with the standard lifecycle of a special purpose acquisition company, which prioritizes preserving capital for a future merger rather than providing income to investors. Consequently, the overall growth and income profile is characterized entirely by potential capital appreciation upon the completion of a business combination, with no current income generation or historical growth trajectory to analyze.

同行比较

Artius II Acquisition Inc. (AACBU) 在壳公司行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
Artius II Acquisition Inc. AACBU N/A N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

壳公司行业平均市盈率为82.8倍。Artius II Acquisition Inc.的市盈率为N/A。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于Artius II Acquisition Inc.

Artius II Acquisition Inc. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on technology enabled businesses that offer technology software and services, or financial services. The company was incorporated in 2024 and is based in New York, New York.

公司简介以英文显示。

访问官网 →

关键指标

市值
N/A
市盈率
N/A
52周最高
$12.15
52周最低
$10.25
平均成交量
88

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NASDAQ
国家
United States